Literature DB >> 9255792

Direct demonstration of MuSK involvement in acetylcholine receptor clustering through identification of agonist ScFv.

M H Xie1, J Yuan, C Adams, A Gurney.   

Abstract

MuSK is a tyrosine kinase localized to the postsynaptic surface of the neuromuscular junction. We have searched for modulators of MuSK function using a library of human single chain variable region antibodies (scFv) that can be displayed on M13 phage or expressed as soluble protein. A panel of 21 independent MuSK-specific scFv, identified in a screen for binding to MuSK-Fc immunoadhesin, were examined for ability to induce proliferation in a factor dependent cell line (Ba/F3) through a chimeric receptor, MuSK-Mpl. Four of the scFv induced a proliferative response, suggesting an ability to induce dimerization of MuSK. These scFv were also able to induce tyrosine phosphorylation of full-length MuSK and retained this ability when re-engineered to be expressed as authentic (and dimeric) human IgG molecules. Addition of agonist scFv to a cultured myotube cell line induced AChR clustering and tyrosine phosphorylation. These results provide direct evidence that MuSK activation is capable of triggering a key event in neuromuscular junction formation and further demonstrate that large libraries of phage-displayed scFv provide a robust method for generating highly specific agonist agents.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9255792     DOI: 10.1038/nbt0897-768

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  17 in total

1.  The actin-driven movement and formation of acetylcholine receptor clusters.

Authors:  Z Dai; X Luo; H Xie; H B Peng
Journal:  J Cell Biol       Date:  2000-09-18       Impact factor: 10.539

2.  Constitutively active MuSK is clustered in the absence of agrin and induces ectopic postsynaptic-like membranes in skeletal muscle fibers.

Authors:  G Jones; C Moore; S Hashemolhosseini; H R Brenner
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

3.  Increasing MuSK activity delays denervation and improves motor function in ALS mice.

Authors:  María J Pérez-García; Steven J Burden
Journal:  Cell Rep       Date:  2012-08-30       Impact factor: 9.423

4.  Animal models of antimuscle-specific kinase myasthenia.

Authors:  David P Richman; Kayoko Nishi; Michael J Ferns; Joachim Schnier; Peter Pytel; Ricardo A Maselli; Mark A Agius
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

5.  Human monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism.

Authors:  Claire L Dobson; Sarah Main; Philip Newton; Matthieu Chodorge; Karen Cadwallader; Robin Humphreys; Vivian Albert; Tristan J Vaughan; Ralph R Minter; Bryan M Edwards
Journal:  MAbs       Date:  2009-11-11       Impact factor: 5.857

Review 6.  Structure and activation of MuSK, a receptor tyrosine kinase central to neuromuscular junction formation.

Authors:  Stevan R Hubbard; Kavitha Gnanasambandan
Journal:  Biochim Biophys Acta       Date:  2013-03-05

Review 7.  Structural mechanisms of the agrin-LRP4-MuSK signaling pathway in neuromuscular junction differentiation.

Authors:  Yinong Zong; Rongsheng Jin
Journal:  Cell Mol Life Sci       Date:  2012-11-22       Impact factor: 9.261

8.  Beyond natural antibodies: the power of in vitro display technologies.

Authors:  Andrew R M Bradbury; Sachdev Sidhu; Stefan Dübel; John McCafferty
Journal:  Nat Biotechnol       Date:  2011-03       Impact factor: 54.908

9.  Directed evolution of a three-finger neurotoxin by using cDNA display yields antagonists as well as agonists of interleukin-6 receptor signaling.

Authors:  Mohammed Naimuddin; Suzuko Kobayashi; Chihiro Tsutsui; Masayuki Machida; Naoto Nemoto; Takafumi Sakai; Tai Kubo
Journal:  Mol Brain       Date:  2011-01-07       Impact factor: 4.041

10.  Nerve-independent formation of a topologically complex postsynaptic apparatus.

Authors:  Terrance T Kummer; Thomas Misgeld; Jeff W Lichtman; Joshua R Sanes
Journal:  J Cell Biol       Date:  2004-03-22       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.